NITROMED, INC.
Patent Owner
Stats
- 5 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Aug 10, 2010 most recent publication
Details
- 5 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,117 Total Citation Count
- May 10, 1995 Earliest Filing
- 56 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
7556824 Transdermal patch composition for treating vascular diseases characterized by nitric oxide insufficiencyOct 07, 03Jul 07, 09[A61K, A61F, A61L]
7537785 Composition for treating vascular diseases characterized by nitric oxide insufficiencyOct 20, 03May 26, 09[A61K, B82B]
6635273 Methods of treating vascular diseases characterized by nitric oxide insufficiencyOct 27, 00Oct 21, 03[A61K, C07D, A61L]
6087479 Localized use of nitric oxide-adducts to prevent internal tissue damageJun 02, 95Jul 11, 00[A61K]
5958926 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their usesSep 01, 98Sep 28, 99[A61K, C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
7772278 Nitrosated and nitrosylated prostaglandins, compositions and methods of useExpiredSep 24, 08Aug 10, 10[A61K, C07C]
7708989 Methods of treating vascular diseases characterized by nitric oxide insufficiencyExpiredOct 27, 03May 04, 10[A61K, A01N]
2010/0068,267 COMPOSITIONS FOR TREATING VASCULAR DISEASES CHARACTERIZED BY NITRIC OXIDE INSUFFICIENCYAbandonedSep 22, 09Mar 18, 10[A61K]
2009/0306,027 GENETIC RISK ASSESSMENT IN HEART FAILURE: IMPACT OF THE GENETIC VARIATION OF G-PROTEIN BETA 3 SUBUNIT POLYMORPHISMAbandonedApr 04, 07Dec 10, 09[A61K]
2009/0253,662 GENETIC RISK ASSESSMENT IN HEART FAILURE: IMPACT OF GENETIC VARIATION OF ALDOSTERONE SYNTHASE PROMOTER POLYMORPHISMAbandonedOct 04, 06Oct 08, 09[A61K, A61P]
2009/0192,128 GENETIC RISK ASSESSMENT IN HEART FAILURE: IMPACT OF GENETIC VARIATION OF BETA 1 ADRENERGIC RECEPTOR GLY389ARG POLYMORPHISMAbandonedOct 04, 06Jul 30, 09[A61K]
2009/0118,293 METHODS FOR REDUCING HOSPITALIZATIONS RELATED TO HEART FAILUREAbandonedOct 31, 08May 07, 09[A61K, A61P]
2009/0075,956 Genetic Risk Assessment in Heart Failure: Impact of the Genetic Variation of NOS3AbandonedApr 07, 06Mar 19, 09[A61K, A61P]
7449595 Nitrosated and nitrosylated prostaglandins, compositions and methods of useExpiredDec 19, 06Nov 11, 08[C07C]
2008/0226,752 KITS OF HYDRALAZINE COMPOUNDS AND ISOSORBIDE DINITRATE AND/OR ISOSORBIDE MONONITRATEAbandonedMar 21, 08Sep 18, 08[A61K]
2008/0009,498 Phosphodiesterase inhibitors and nitric oxide donors, compositions and methods of useAbandonedJun 27, 07Jan 10, 08[A61K, A61P]
2007/0191,377 Methods for treating blood disorders with nitric oxide donor compoundsAbandonedMar 31, 05Aug 16, 07[A61K]
7235237 Methods of treating vascular diseases characterized by nitric oxide insufficiencyExpiredMay 02, 01Jun 26, 07[A61K]
2007/0010,571 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of useAbandonedAug 20, 04Jan 11, 07[A61K, C07D]
2006/0014,829 Methods for reducing hospitalizations related to heart failureAbandonedJul 18, 05Jan 19, 06[A61K]
2005/0187,222 Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compoundsAbandonedApr 20, 05Aug 25, 05[A61K, C07D]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.